Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Home
Books
Conferences
DVDs
Newsletters
Form 483
s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
FDAnews Drug Daily Bulletin
> Abbott Labs Eyes Russian Pharmaceutical Market
FDAnews Drug Daily Bulletin
Oct. 16, 2012
| Vol. 9 No. 203
Abbott Labs Eyes Russian Pharmaceutical Market
Abbott Laboratories may be looking to acquire the manufacturing facilities of Russian drug maker Petrovax Pharm. The news marks the company’s growing focus in one of the fastest growing pharmaceutical markets.
NASDAQ
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
Pharma Blog Watch
Prices of Pharmaceuticals Likely to Increase in Pakistan
Teva Stops Filing For Patents in Israel; Will File for Them in Switzerland Instead
U.S. Court Finds Novo Nordisk Prandin Diabetes Drug Patent Invalid